Archer Materials Limited (ASX:AXE) Advances Biochip Technology
Archer Materials Limited (ASX:AXE) has progressed its Biochip technology, improving accuracy for chronic kidney disease testing.
Archer Materials Limited (ASX:AXE) has progressed its Biochip technology, improving accuracy for chronic kidney disease testing.
NIMY Resources Limited announces significant discoveries of copper and gallium at the Mons Project, highlighting their exploration success.
Beam Communications revealed its FY24 financials, highlighting growth in recurring revenue, cost-saving initiatives, and a strategic focus for the future.
Cann Group Limited (ASX: CAN) raises $2 million to support its growth initiatives through a successful entitlement offer.
IAG announces a long-term strategic partnership with RACQ to enhance insurance services in Queensland.
SDI Limited reports a record profit for FY24, reflecting strong operational efficiency and growth in European markets.
Tower Limited (ASX:TWR) reveals strong FY24 results with significant profits, a final dividend declaration, and plans for capital return.
Fisher & Paykel Healthcare reports record revenue and profit for 1H FY2025, with an interim dividend announcement.
Cyclopharm Limited secures purchase orders for its Technegas System from US VA hospitals, enhancing healthcare for veterans.
Emyria Limited (ASX: EMD) raises $2.525M to enhance its mental health treatment programs targeting PTSD and depression.